Invasive Group B Streptococcal Disease Among Nonpregnant Adults: Alaska, 2004–2023
We describe the epidemiology of invasive group B streptococcal (GBS) disease among nonpregnant Alaska adults using statewide surveillance data. During 2004-2023, 880 cases of invasive GBS disease were reported for an age-adjusted annual incidence of 9.1 (95% confidence interval [CI], 8.5-9.7) cases per 100 000 adults. Incidence increased 1.9-fold (95% CI, 1.6-2.2) between 2004-2013 and 2014-2023. Adults aged ≥65 years had a 4.4-fold higher risk of invasive disease compared to younger adults, and 47% of adults with invasive GBS had diabetes. Health care providers should be aware of populations at increased risk, potentially allowing for more prompt treatment.
Authors
- Marcella Harker‐Jones
- Jonathan Steinberg (ORCID: https://orcid.org/0000-0001-8446-5304)
- Joseph B McLaughlin (ORCID: https://orcid.org/0009-0002-7818-7226)
- Alisa Reasonover
- Victoria A. Balta (ORCID: https://orcid.org/0000-0003-0685-6697)
- Stephanie Massay
- Marc Fischer (ORCID: https://orcid.org/0009-0001-6394-3490)
- T. Kretz
- Sara Bressler (ORCID: https://orcid.org/0000-0002-6439-9714)
- Laurie Orell (ORCID: https://orcid.org/0000-0003-3608-5854)
Institutions
- Centers for Disease Control and Prevention (US)
- Alaska Department of Health and Social Services (US)
- National Center for Emerging and Zoonotic Infectious Diseases (US)
- Office of Tribal Affairs and Strategic Alliances (US)
- Epidemic Intelligence Service (US)
Publication Details
- Journal
- The Journal of Infectious Diseases
- Published
- 2025-02-27
- DOI
- https://doi.org/10.1093/infdis/jiaf055
- Citations
- 3
- Primary Topic
- Neonatal and Maternal Infections
- Type
- article
- Field-Weighted Citation Impact
- 5.64
Funders
- Centers for Disease Control and Prevention